-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Covetrus (NASDAQ:CVET) Stock Rating Upgraded by TheStreet
Covetrus (NASDAQ:CVET) Stock Rating Upgraded by TheStreet
TheStreet upgraded shares of Covetrus (NASDAQ:CVET – Get Rating) from a d+ rating to a c- rating in a report published on Wednesday morning, TheStreetRatingsTable reports.
Separately, Stifel Nicolaus downgraded Covetrus from a buy rating to a hold rating and set a $22.00 target price for the company. in a report on Monday, June 13th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $21.40.
Get Covetrus alerts:Covetrus Stock Down 0.1 %
CVET opened at $20.88 on Wednesday. Covetrus has a fifty-two week low of $13.39 and a fifty-two week high of $21.20. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.08 and a current ratio of 1.88. The company has a market capitalization of $2.93 billion, a P/E ratio of -208.80 and a beta of 1.63. The stock has a fifty day moving average of $20.83 and a 200-day moving average of $19.09.
Covetrus (NASDAQ:CVET – Get Rating) last posted its earnings results on Thursday, August 4th. The company reported $0.20 earnings per share for the quarter, hitting analysts' consensus estimates of $0.20. Covetrus had a positive return on equity of 6.83% and a negative net margin of 0.28%. The company had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.23 billion. On average, equities analysts expect that Covetrus will post 0.84 EPS for the current year.Insider Activity at Covetrus
In related news, CEO Benjamin Wolin sold 5,292 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $20.80, for a total value of $110,073.60. Following the completion of the transaction, the chief executive officer now owns 199,780 shares of the company's stock, valued at $4,155,424. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.40% of the stock is owned by insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Crossmark Global Holdings Inc. acquired a new position in Covetrus in the first quarter valued at about $170,000. Profund Advisors LLC grew its position in Covetrus by 19.6% in the first quarter. Profund Advisors LLC now owns 15,485 shares of the company's stock valued at $260,000 after acquiring an additional 2,543 shares during the last quarter. D. E. Shaw & Co. Inc. grew its position in Covetrus by 87.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,028,735 shares of the company's stock valued at $20,544,000 after acquiring an additional 479,008 shares during the last quarter. Campbell & CO Investment Adviser LLC bought a new position in Covetrus in the first quarter valued at about $343,000. Finally, Tamarack Advisers LP bought a new position in Covetrus in the first quarter valued at about $2,166,000. Institutional investors and hedge funds own 92.20% of the company's stock.
Covetrus Company Profile
(Get Rating)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Featured Stories
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
TheStreet upgraded shares of Covetrus (NASDAQ:CVET – Get Rating) from a d+ rating to a c- rating in a report published on Wednesday morning, TheStreetRatingsTable reports.
据The StreetRatingsTable报道,在周三上午发布的一份报告中,华尔街将纳斯达克(Covetrus:CVET-GET Rating)的股票评级从D+上调至C-。
Separately, Stifel Nicolaus downgraded Covetrus from a buy rating to a hold rating and set a $22.00 target price for the company. in a report on Monday, June 13th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $21.40.
另外,Stifel Nicolaus将Covetrus的评级从买入下调至持有,并为该公司设定了22.00美元的目标价。在6月13日星期一的一份报告中。一名投资分析师对该股的评级为卖出,五名分析师对该股的评级为持有。根据MarketBeat.com的数据,该股目前的普遍评级为持有,平均目标价为21.40美元。
Covetrus Stock Down 0.1 %
雪茄类股下跌0.1%
CVET opened at $20.88 on Wednesday. Covetrus has a fifty-two week low of $13.39 and a fifty-two week high of $21.20. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.08 and a current ratio of 1.88. The company has a market capitalization of $2.93 billion, a P/E ratio of -208.80 and a beta of 1.63. The stock has a fifty day moving average of $20.83 and a 200-day moving average of $19.09.
CVeT周三开盘报20.88美元。Covetrus的52周低点为13.39美元,52周高位为21.20美元。该公司的负债权益比率为0.65,速动比率为1.08,流动比率为1.88。该公司市值29.3亿美元,市盈率为-208.80,贝塔系数为1.63.该股的50日移动均线切入位为20.83美元,200日移动均线切入位为19.09美元。
Insider Activity at Covetrus
Covetrus的内幕活动
In related news, CEO Benjamin Wolin sold 5,292 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $20.80, for a total value of $110,073.60. Following the completion of the transaction, the chief executive officer now owns 199,780 shares of the company's stock, valued at $4,155,424. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.40% of the stock is owned by insiders.
在相关新闻中,首席执行官本杰明·沃林在日期为8月9日(星期二)的交易中出售了5,292股该公司股票。这只股票的平均售价为20.80美元,总价值为110,073.60美元。交易完成后,首席执行官现在拥有199,780股公司股票,价值4,155,424美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过美国证券交易委员会网站。该公司0.40%的股份由内部人士持有。
Institutional Inflows and Outflows
机构资金流入和流出
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Crossmark Global Holdings Inc. acquired a new position in Covetrus in the first quarter valued at about $170,000. Profund Advisors LLC grew its position in Covetrus by 19.6% in the first quarter. Profund Advisors LLC now owns 15,485 shares of the company's stock valued at $260,000 after acquiring an additional 2,543 shares during the last quarter. D. E. Shaw & Co. Inc. grew its position in Covetrus by 87.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,028,735 shares of the company's stock valued at $20,544,000 after acquiring an additional 479,008 shares during the last quarter. Campbell & CO Investment Adviser LLC bought a new position in Covetrus in the first quarter valued at about $343,000. Finally, Tamarack Advisers LP bought a new position in Covetrus in the first quarter valued at about $2,166,000. Institutional investors and hedge funds own 92.20% of the company's stock.
对冲基金和其他机构投资者最近买卖了该股的股票。今年第一季度,Crossmark Global Holdings Inc.收购了Covetrus的一个新头寸,价值约为17万美元。Profund Advisors LLC在第一季度将其在Covetrus的头寸增加了19.6%。Profund Advisors LLC现在拥有15,485股该公司的股票,价值260,000美元,在上个季度又购买了2,543股。D.E.Shaw&Co.Inc.在第四季度将其在Covetrus的头寸增加了87.1%。D.E.Shaw&Co.Inc.在上个季度增持了479,008股后,现在持有1,028,735股该公司股票,价值20,544,000美元。Campbell&CO Investment Adviser LLC在第一季度购买了Covetrus的新头寸,价值约343,000美元。最后,Tamarack Advisers LP在第一季度购买了Covetrus的一个新头寸,价值约为2,166,000美元。机构投资者和对冲基金持有该公司92.20%的股票。
Covetrus Company Profile
Covetrus公司简介
(Get Rating)
(获取评级)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Covetrus,Inc.及其子公司是一家动物保健技术和服务公司。它从事向批发和零售客户销售动物健康消耗品,包括专利和Covetrus品牌产品、小型设备、实验室产品、大型设备、设备维修服务、品牌和仿制药、疫苗、外科产品、诊断测试、感染控制产品、寄生虫药以及维生素和补充剂。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
- 免费获取StockNews.com关于Covetrus的研究报告(CVeT)
- MarketBeat:回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- 雷神工业走出谷底
- 利润下降对CarMax价值主张的挑战
- 让Paychex股票为您努力工作
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《椰子日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Covetrus和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧